Article
RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin
1 Nov 2014
Abstract excerpt
Metastatic cancer of unknown primary (CUP) accounts for up to 5% of all new cancer cases, with a 5-year survival rate of only 10%. Accurate identification of tissue of origin would allow for directed, personalized therapies to improve clinical outcomes. Our objective was to use transcriptome sequencing (RNA-Seq) to identify lineage-specific biomarker signatures for the cancer types that most commonly metastasize...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
